Real-time enrollment status for this relapsed/refractory multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:39 AM UTC
| NCT Number | NCT05722418 |
| Recruiting Status | Recruiting |
| Condition | Relapsed/Refractory Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Caribou Biosciences, Inc. |
| Last Updated on CT.gov | September 25, 2025 (Sep 25, 2025) |
As of July 13, 2026: Clinical trial NCT05722418 is currently recruiting participants. This clinical trial study for relapsed/refractory multiple myeloma is actively seeking new participants at 16 locations across the United States. The study is sponsored by Caribou Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05722418 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05722418 was last updated Sep 25, 2025 (September 25, 2025). HelloStudys verifies this status automatically.